Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Assets (2020 - 2023)

Historic Assets for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to $271.7 million.

  • Terns Pharmaceuticals' Assets rose 4107.31% to $271.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $271.7 million, marking a year-over-year increase of 4107.31%. This contributed to the annual value of $287.0 million for FY2022, which is 7077.77% up from last year.
  • According to the latest figures from Q3 2023, Terns Pharmaceuticals' Assets is $271.7 million, which was up 4107.31% from $289.7 million recorded in Q2 2023.
  • Terns Pharmaceuticals' 5-year Assets high stood at $301.3 million for Q1 2023, and its period low was $92.3 million during Q4 2020.
  • For the 4-year period, Terns Pharmaceuticals' Assets averaged around $205.9 million, with its median value being $190.3 million (2021).
  • As far as peak fluctuations go, Terns Pharmaceuticals' Assets tumbled by 2294.97% in 2022, and later surged by 9998.41% in 2023.
  • Over the past 4 years, Terns Pharmaceuticals' Assets (Quarter) stood at $92.3 million in 2020, then soared by 82.11% to $168.1 million in 2021, then soared by 70.78% to $287.0 million in 2022, then fell by 5.34% to $271.7 million in 2023.
  • Its last three reported values are $271.7 million in Q3 2023, $289.7 million for Q2 2023, and $301.3 million during Q1 2023.